×
Time:2024-01-13
Recently, 鳳凰彩票785cc has secured approval for domestic drug registration of its API Coenzyme Q10, positioning the company as the first enterprise to receive such approval since the issuance of the National Medical Products Administration (NMPA)'s Announcement on Matters Related to Further Improving the Review, Approval, and Supervision of Drugs in 2019. This significant milestone indicates that our Coenzyme Q10 is at the forefront of the industry and paves the way for a new API market, presenting fresh opportunities for our development.
About Coenzyme Q10
Coenzyme Q10, a fat-soluble antioxidant, plays a crucial role in fortifying the myocardium, preventing heart aging, preventing and combating cancer, maintaining cardiovascular health, and enhancing overall vitality. The significant market demand for Coenzyme Q10 exists both domestically and internationally. The production of API Coenzyme Q10 necessitates stringent quality control and safety inspections, leading to rigorous requirements for production processes and product quality. 鳳凰彩票785cc stands out as the inaugural company to receive such approval and recognition, demonstrating the company’s capability to produce high-quality API Coenzyme Q10 since the drug approval reform by the NMPA in 2019.
In its role as a guardian of nutrition and health, 鳳凰彩票785cc is committed to the journey of open innovation. Starting from addressing future and potential market needs, we collaborate with academia and industry to delve into the cutting edges of chemical and biological science and technology and foster innovation and advancement, leading to the successful development of products like the Vitamin Series, Moxifloxacin Hydrochloride, and Taurine. 鳳凰彩票785cc aims to create value for the entire industry and society, establishing a "Safety Moat" for human health.
On June 27, the seventh Yue Health Lecture Series, hosted by the Shaoxing Health Management Association, co-hosted by the Shaoxing Medical Association, and organized by 鳳凰彩票785cc, was held in Xinchang.
View details
On May 27, the launch ceremony of Shaoxing's 2026 Love Enterprise Action campaign was grandly held under the theme of Supporting Enterprises with Care, Empowering the Future with Intelligence. At the event, 鳳凰彩票785cc was proud to receive three distinguished awards: Top 100 Private Enterprises in Shaoxing 2026, Top 10 Enterprises by R&D Investment in Shaoxing 2026, and Top 10 Foreign Trade Exporters in Shaoxing 2026. Ms. Zhang Liying, Vice President of the Company, attended the ceremony and accepted the awards on behalf of 鳳凰彩票785cc. These recognitions reflect the strong endorsement of 鳳凰彩票785cc’s overall strength, innovation capabilities, and global competitiveness by the Shaoxing Municipal Party Committee, the Municipal Government, and the wider community. They also underscore 鳳凰彩票785cc’s role as a benchmark enterprise and a key contributor to regional economic development.
View details
In 2026, 鳳凰彩票785cc's synthetic anethole officially received approval as a new food additive variety in China. 鳳凰彩票785cc became the first company in the country to obtain food-grade certification for this product, filling a critical gap in domestic food-grade certification for synthetic anethole.
View details